These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28192118)

  • 21. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
    Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of a secreted protein by the myxoid liposarcoma oncogene.
    Kuroda M; Wang X; Sok J; Yin Y; Chung P; Giannotti JW; Jacobs KA; Fitz LJ; Murtha-Riel P; Turner KJ; Ron D
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5025-30. PubMed ID: 10220412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
    Safavi S; Järnum S; Vannas C; Udhane S; Jonasson E; Tomic TT; Grundevik P; Fagman H; Hansson M; Kalender Z; Jauhiainen A; Dolatabadi S; Stratford EW; Myklebost O; Eriksson M; Stenman G; Schneider-Stock R; Ståhlberg A; Åman P
    Oncotarget; 2016 Jan; 7(1):433-45. PubMed ID: 26595521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
    Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.
    Hosaka T; Nakashima Y; Kusuzaki K; Murata H; Nakayama T; Nakamata T; Aoyama T; Okamoto T; Nishijo K; Araki N; Tsuboyama T; Nakamura T; Toguchida J
    J Mol Diagn; 2002 Aug; 4(3):164-71. PubMed ID: 12169678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas.
    Thelin-Järnum S; Lassen C; Panagopoulos I; Mandahl N; Aman P
    Int J Cancer; 1999 Sep; 83(1):30-3. PubMed ID: 10449603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas.
    Domoto H; Hosaka T; Oikawa K; Ohbayashi T; Ishida T; Izumi M; Iwaya K; Toguchida J; Kuroda M; Mukai K
    Pathol Int; 2002 Aug; 52(8):497-500. PubMed ID: 12366807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.
    Wei YC; Li CF; Eng HL; Yeh MC; Lin CN; Huang HY
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):477-80. PubMed ID: 18091394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro.
    Künstlinger H; Fassunke J; Schildhaus HU; Brors B; Heydt C; Ihle MA; Mechtersheimer G; Wardelmann E; Büttner R; Merkelbach-Bruse S
    Oncotarget; 2015 Aug; 6(24):20215-30. PubMed ID: 26036639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
    Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.
    Matsui Y; Ueda T; Kubo T; Hasegawa T; Tomita Y; Okamoto M; Myoui A; Kakunaga S; Yasui N; Yoshikawa H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):437-40. PubMed ID: 16884691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
    Svec D; Dolatabadi S; Thomsen C; Cordes N; Shannon M; Fitzpatrick P; Landberg G; Åman P; Ståhlberg A
    Lab Invest; 2018 Jul; 98(7):957-967. PubMed ID: 29588491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
    Narendra S; Valente A; Tull J; Zhang S
    Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.
    Germano G; Frapolli R; Simone M; Tavecchio M; Erba E; Pesce S; Pasqualini F; Grosso F; Sanfilippo R; Casali PG; Gronchi A; Virdis E; Tarantino E; Pilotti S; Greco A; Nebuloni M; Galmarini CM; Tercero JC; Mantovani A; D'Incalci M; Allavena P
    Cancer Res; 2010 Mar; 70(6):2235-44. PubMed ID: 20215499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.
    Olofsson A; Willén H; Göransson M; Engström K; Meis-Kindblom JM; Stenman G; Kindblom LG; Aman P
    Int J Oncol; 2004 Nov; 25(5):1349-55. PubMed ID: 15492825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
    Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
    Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma.
    Trautmann M; Cyra M; Isfort I; Jeiler B; Krüger A; Grünewald I; Steinestel K; Altvater B; Rossig C; Hafner S; Simmet T; Becker J; Åman P; Wardelmann E; Huss S; Hartmann W
    Mol Cancer Ther; 2019 Apr; 18(4):834-844. PubMed ID: 30787173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene.
    Suzuki K; Matsui Y; Endo K; Kubo T; Hasegawa T; Kimura T; Ohtani O; Yasui N
    Anticancer Res; 2010 Nov; 30(11):4679-83. PubMed ID: 21115923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.